Neuropathology of brain and spinal malformations in a case of monosomy 1p36
© Shiba et al.; licensee BioMed Central Ltd. 2013
Received: 18 July 2013
Accepted: 18 July 2013
Published: 2 August 2013
Monosomy 1p36 is the most common subtelomeric chromosomal deletion linked to mental retardation and seizures. Neuroimaging studies suggest that monosomy 1p36 is associated with brain malformations including polymicrogyria and nodular heterotopia, but the histopathology of these lesions is unknown. Here we present postmortem neuropathological findings from a 10 year-old girl with monosomy 1p36, who died of respiratory complications. The findings included micrencephaly, periventricular nodular heterotopia in occipitotemporal lobes, cortical dysgenesis resembling polymicrogyria in dorsolateral frontal lobes, hippocampal malrotation, callosal hypoplasia, superiorly rotated cerebellum with small vermis, and lumbosacral hydromyelia. The abnormal cortex exhibited “festooned” (undulating) supragranular layers, but no significant fusion of the molecular layer. Deletion mapping demonstrated single copy loss of a contiguous 1p36 terminal region encompassing many important neurodevelopmental genes, among them four HES genes implicated in regulating neural stem cell differentiation, and TP73, a monoallelically expressed gene. Our results suggest that brain and spinal malformations in monosomy 1p36 may be more extensive than previously recognized, and may depend on the parental origin of deleted genes. More broadly, our results suggest that specific genetic disorders may cause distinct forms of cortical dysgenesis.
KeywordsPeriventricular nodular heterotopia Hippocampal malrotation Cortical dysgenesis Malformations of cortical development Hydromyelia Mental retardation Epilepsy
Monosomy 1p36 is the most common subtelomeric chromosomal deletion syndrome, with an estimated incidence of 1/5000-1/10000 births . Of the ~95% of deletions that arise de novo, 60% affect the maternally derived chromosome , and manifest as various kinds of chromosomal rearrangements (e.g., interstitial deletions, derivative chromosomes, and more complex rearrangements, as well as pure terminal deletions). The clinical phenotype of monosomy 1p36 includes mental retardation, developmental delay, muscular hypotonia, speech delay, epilepsy, behavioral disorders (including panic, aggressiveness, and self-injury), sensorineural hearing loss, eye/vision problems, congenital heart defects, cardiomyopathy, gastrointestinal problems, precocious puberty, hyperphagia/obesity, and dysmorphic features (deep-set eyes, flat nasal bridge, pointed chin, large and late-closing anterior fontanel, and clinodactyly) [1–5]. Mental retardation and developmental delay are seen in nearly 100% of patients, and are usually moderate or severe [5, 6]. Generalized hypotonia is observed in >90% of patients, and epilepsy in 50-80% [4, 6].
The chromosome deletion in most cases maps to the distal 10.5 Mb of 1p36, although the size varies and there is no common break point . There is little correlation between the deletion size and the number of clinical features; even relatively small deletions (<3 Mb) can present with most of the typical phenotypic features [3, 7]. Indeed, it has been suggested that some features of monosomy 1p36 might result from positional effects rather than a simple contiguous gene deletion . On the other hand, the severity of neurological deficits including epilepsy, mental retardation and sensorineural hearing loss, as well as congenital heart diseases, has been suggested to correlate with the deletion size [6, 8]. Furthermore, some specific phenotypes in the monosomy 1p36 syndrome — including polymicrogyria (PMG), hyperphagia/obesity, mental retardation, seizures, hearing loss, and periventricular nodular heterotopia (PNH) — have been linked to critical regions within 1p36, each of which nevertheless contains multiple genes [2, 4, 9–11].
Although neuropsychiatric abnormalities are pivotal phenotypes in monosomy 1p36, their pathogenesis remains poorly understood. In most cases, neuroimaging reveals only mild or nonspecific changes such as microcephaly, ventriculomegaly, cerebral atrophy, abnormal patchy signal in white matter, and delayed myelination. Recently, however, evidence has accumulated that some fraction of monosomy 1p36 cases are affected with significant developmental brain malformations, including PMG, PNH, hypoplasia or agenesis of the corpus callosum, holoprosencephaly, cerebellar hypoplasia, and choroid plexus hyperplasia [10, 12–19]. In one series, for example, 13 of 64 (20.3%) patients with monosomy 1p36 showed neuroimaging evidence of PMG .
In the present case report, we present the first neuropathological analysis of brain and spinal cord malformations in monosomy 1p36, from postmortem examination of a girl who died at 10 years of age. Our findings reveal new details of the malformations, and suggest that PMG in these patients represents a distinct form of cortical dysgenesis.
The subject was delivered at 39 weeks of gestation by caesarean section for breech position, to a 22 year-old, gravida 2, para 1 (1 spontaneous abortion) mother who had received special education in school. The father was a nonconsanguineous 37 year-old man with no known medical problems or significant family history. Birth weight was 2035 g (−3.7 SD). Apgar scores were 7 at 1 minute and 8 at 5 minutes. Neonatal cardiac evaluation showed a patent ductus arteriosus (PDA) and small ventricular septal defect (VSD). The PDA was ligated at age 7 weeks and the VSD closed spontaneously. She had severe conjugated hyperbilirubinemia transiently during early infancy, along with other findings suggestive of possible Alagille syndrome (posterior embryotoxon and butterfly vertebrae). However, liver biopsy showed no paucity of bile ducts (as present in Alagille syndrome) nor any other disease specific finding. Postnatal growth retardation (height < 5th centile), microcephaly (head circumstance < 5th centile), feeding difficulties, muscular hypotonia, and delayed motor and mental development were also noted. Infantile apneic spells were noted, prompting magnetic resonance imaging (MRI) that revealed cervicomedullary compression at the skull base; this was surgically decompressed. At 8 months of age, the patient was referred to the Department of Medical Genetics and was noted to exhibit dysmorphic features including bilateral low set small malformed ears, prominent forehead, deep set eyes, flat nasal bridge, pointed chin, short neck, and bilateral single transverse creases.
At age 13 months, growth hormone deficiency of unknown etiology was diagnosed and treated with growth hormone replacement therapy. The patient had severe gastro-esophageal reflux causing recurrent aspiration pneumonia; Nissen fundoplication with gastrostomy was done at 15 months of age. Precocious secondary sexual characteristics and clitoromegaly were noted at 22 months. The first apparent generalized tonic-clonic seizure occurred at age 5 years; seizures progressed, and were ultimately treated with combination anti-epileptic drug therapy. On serial neurological examinations, the patient never spoke any words nor walked, and her development remained profoundly delayed. She also had myopia with astigmatism and sensorineural hearing loss bilaterally. Self-injurious behavior (arm chewing) and teeth grinding were observed.
G-band karyotyping of peripheral blood lymphocytes showed a terminal deletion of chromosome 1p, read as 46,XX,del(1)(p36.31). The deletion in this region was confirmed by fluorescence in situ hybridization (FISH) using a subtelomeric DNA probe specific for the region, 1p36.3 (D1Z2; Oncor, Inc., cat #p5000-DG). The mother’s karyotype was normal; the father’s karyotype was not available.
The patient died at age 10 years from cardiorespiratory failure.
General autopsy findings
A complete autopsy was performed with familial consent. The postmortem interval was 23.5 hours. The lungs showed patchy severe pneumonia, with postmortem lung cultures positive for Pseudomonas aeruginosa. The heart showed dysplasia of atrioventricular valves, but no cardiomyopathy. No hepatic or renal abnormalities were present.
Materials and methods
The brain was removed within 48 hours after death and was fixed for two weeks in 10% formalin. Representative samples of formalin-fixed brain and spinal cord were embedded in paraffin, sectioned at 6 μm, and mounted on glass slides. Hematoxylin and eosin (H-E), Luxol fast blue (LFB), and cresyl violet (Nissl) stains utilized standard protocols. Age-matched normal human brain specimens were studied as controls.
Single-label immunoperoxidase staining was done using standard procedures. Double-label immunofluorescence was done as described . The following primary antibodies were used: rabbit polyclonal antibodies against glial fibrillary acidic protein (GFAP; DAKO, 1:2000); mouse monoclonal antibodies against neurofilament heavy chain (clone N52; Chemicon, Temecula, CA; diluted 1:300); microtubule-associated protein 1B (MAP1B; Chemicon; 1:400), microtubule-associated protein 2 (MAP2; Chemicon; 1:500), synaptophysin (Chemicon; 1:400), rabbit polyclonal antibodies against calretinin (CR; Swant, Bellinzona, Switzerland; 1:2000). Primary antibody specificity was verified in control cortex. As a control for nonspecific binding of secondary antibodies, primary antibodies were omitted from some incubations.
Brightfield and fluorescence images were acquired using a Carl Zeiss Axio Imager Z1 microscope equipped with motorized stage and MosaiX software (Zeiss, USA). Images were photographed digitally and processed using Photoshop (Adobe, San Jose, CA, USA) to optimize brightness, contrast, and resolution. To map the positions of cells associated with deep and superficial cortical layers, N52+ cells and CR + cells (respectively) were plotted using different color dots (N52+ cells green, CR + cells red) against a black background, as described .
High-resolution chromosomal deletion mapping
Chromosomal deletions and duplications were analyzed using a bacterial artificial chromosome (BAC)-based microarray (SignatureChip v3.0, Signature Genomic Laboratories, Spokane, WA) as described previously .
Histopathology of PMG-like cortical dysgenesis
Histopathology of periventricular heterotopia
The neuronal identity of PNH and adjacent thin laminar heterotopia along the walls of the occipital and temporal horns was confirmed by immunohistochemistry to detect synaptophysin (Figure 3L). In addition, many numerous smaller nodular or linear heterotopia (<3 mm), often aligned along the interface between the subventricular zone and white matter, were synaptophysin immunoreactive (Figure 3L). These findings indicated that heterotopia, like regions of cortical dysgenesis, were more extensive than appreciated from macroscopic examination. Also, the PNH contained multiple neuron types, including N52+ pyramidal neurons as well as CR + interneurons (Figure 3M). Interestingly, in some PNHs, N52+ neurons were located predominantly in the center of the nodule, and CR + interneurons around the outside (Figure 3M, nodule at right). This observation suggests that some nodules may have had a rudimentary laminar structure.
Histopathology of the brainstem, cerebellum, and spinal cord
The inferior olivary nuclei appeared mildly hypoconvoluted (Figure 3N). The cerebellar cortex exhibited patchy loss of Purkinje neurons; the dentate nuclei were unremarkable. The spinal central canal was moderately dilated at lower thoracic and upper lumbar levels (Figure 3O).
Histopathology of the hippocampus
Chromosomal deletion mapping and affected genes
Genes related to development and function of nervous system within region of 1p36.21-1p36.33 deletion
Null mouse phenotype
kelch-like 17 (Drosophila)
Hairy and enhancer of split 4 (Drosophila)
HES gene family
sodium channel, nonvoltage-gated 1, delta
highly expressed in pyramidal neurons
dishevelled, dsh homolog 1 (Drosophila)
SJS (AR), CMT2A (AR)
abnormal social interactions
matrix-remodelling associated 8
von Willebrand factor A domain containing 1
peripheral nerve defects
Mindbomb homolog 2 (Drosophila)
ubiquitin ligase for Notch ligands
matrix metallopeptidase 23B
cranial suture closure***
guanine nucleotide binding protein (G protein), beta polypeptide 1
One of three beta subunits of G proteins
GABA A receptor, delta
v-ski sarcoma viral oncogene homolog (avian)
exencephaly, facial clefting, peripheral nerve myelination defects, PHPV, microphthalmos
peroxisomal biogenesis factor 10
ALD (AR), ZS (AR)
phospholipase C, eta 2
Hairy and enhancer of split 5 (Drosophila)
premature neuronal differentiation
synergistic with Hes1, Hes3
tumor protein p63 regulated 1-like
tumor protein p73
Hippocampal, neocortical defects
potassium voltage-gated channel, shaker-related subfamily, beta member 2
Defects of learning and memory
chromodomain helicase DNA binding protein 5
brain development, tumor suppressor gene
Hairy and enhancer of split 3 (Drosophila)
with Hes1, Hes5
acyl-CoA thioesterase 7
Hairy and enhancer of split 2 (Drosophila)
expressed in developing nervous system
congenital hearing loss (AR, AD)
pleckstrin homology domain containing, family G (with RhoGef domain) member 5
lower motor neuron disease (AR)
activates NF kappa B
The current monosomy 1p36 case, with a 6.8 Mb subtelomeric deletion, presented with conspicuous neuropsychiatric abnormalities and other typical clinical manifestations of this syndrome [3, 12]. The patient also had some disorders that are not typically associated with monosomy 1p36, namely transient conjugated hyperbilirubinemia in early infancy, and growth hormone deficiency. Postmortem neuropathological examination revealed significant brain and spinal malformations, including: (1) occipitotemporal PNHs; (2) bifrontal cortical dysgenesis resembling PMG; (3) callosal hypoplasia; (4) hippocampal malrotation; (5) small, anteriorly rotated vermis; (6) simplified inferior olives; and (7) hydromyelia in the lower thoracic and upper lumbar spinal cord. However, the hydromyelia was mild, and may have been secondary to cervicomedullary compression. None of the malformations were detected during life, and the last four have not previously been reported in monosomy 1p36. Thus, our findings suggest that brain and spinal malformations in monosomy 1p36 may have been underestimated in previous studies. The present study may help to raise awareness and increase detection of these malformations in monosomy 1p36 .
Polymicrogyria-like cortical dysgenesis in monosomy 1p36
PMG is a poorly understood malformation characterized by excessive small gyri (often lending the cortex an irregular “Moroccan leather” surface appearance) and fusion of the molecular layer . The first report of “possible polymicrogyria” in monosomy 1p36 was published in 1999 . The presumed PMG in that case involved the left hemisphere, but no brain imaging or neuropathology was shown. More recently, it was reported that 13 of 64 (20%) monosomy 1p36 patients showed MRI evidence of PMG . Interestingly, the apparent PMG affected perisylvian cortex preferentially, and involved the right hemisphere more often than the left. Also, the smallest deletion in that series was the last 4.8 Mb of 1p36, implying a critical region between BAC RP5-1096P7 and the 1p telomere. Subsequent studies have reported perisylvian PMG in three additional monosomy 1p36 patients [13, 18, 19]. Pachygyria and “coarse and nodular” cortex have also been described by neuroimaging in monosomy 1p36 . However, none of the previous reports have documented the macroscopic brain pathology, or the histopathology of PMG in monosomy 1p36. Thus, the accuracy of the PMG diagnosis in monosomy 1p36, and its relation to other forms of PMG (not associated with monosomy 1p36), have remained uncertain.
Neuropathologists have distinguished several histological types of PMG on the basis of laminar morphology, but the significance of these variations is uncertain. The most common types of PMG have been described as “unlayered” and “four-layered”; less frequently, “two-layered” and “six-layered” PMG have been described [52–54]. In the present case, the cortical dysgenesis most resembled “six-layered” PMG. However, different PMG types may occur together in the same brain, and (despite their different morphologies) all seem to exhibit similar relative positions of layer-specific neurons . Also, on neuroimaging, PMG may be difficult to distinguish from other MCDs, such as pachygyria and “cobblestone” malformations involving breaches in the pial surface of the brain, which can also occur together with PMG in the same brain . Recently, it was proposed that fusion of the molecular layer is a defining feature of PMG . By this criterion, cortical dysgenesis in the present case did not qualify as PMG, since little to no fusion of the molecular layer could be discerned (Figure 3). On the other hand, this is the only case of monosomy 1p36 with histopathological studies reported so far, and it is possible that authentic PMG with definite molecular layer fusion might occur in other cases; dysgenesis in the present case might represent a mild form of PMG. Alternatively, monosomy 1p36 may exhibit a unique form of “PMG-like” cortical dysgenesis, always lacking fusion of the molecular layer. Similarly to classic PMG , cortical dysgenesis in the present case showed no overall change in the relative positions of layer-specific neuron types (Figure 3H-K).
Heterotopia in monosomy 1p36
Subcortical heterotopia are caused by defective cell migration from the fetal ventricular zone to the cortical plate, and can appear as scattered neurons, laminar bands, or PNH [52, 56]. The first report of PNH in monosomy 1p36 appeared in 2006 . In that case, multiple PNH were identified in the anterior portion of the left lateral ventricle. Subsequent reports have described multiple PNH bilaterally , and one PNH in the left lateral ventricle  of monosomy 1p36 patients. In the present case, multiple PNH were found in the temporal and occipital horns bilaterally (Figure. 1, 2 and 3). Thus, so far, there appears to be no consistent pattern in the distribution of PNH in monosomy 1p36, in contrast to some other forms of PNH, such as classic bilateral PNH linked to the FLNA gene on chromosome Xq28 .
Interestingly, laminar-like patterns are sometimes observed in PNH. In the present case, infragranular neurons (N52+ large pyramids) were located at the center of a nodule, and supragranular neurons (CR+) at the periphery (Figure 3M). Previous studies of PNH have reported disparate findings. One group reported that PNH contained predominantly supragranular neuron types, with very few infragranular-type neurons . Another group found that PNH contained infragranular neurons at the periphery of nodules, with likely supragranular neurons occupying the center of nodules . Altogether, the available data suggest that PNH may have variable composition, and may perhaps differ according to the genetic or other etiology of the malformation.
Hippocampal malrotation in monosomy 1p36
Neuroimaging studies suggest that hippocampal malrotation occurs relatively frequently in association with other MCDs (22-56%), in seizure disorders (up to 43%), and possibly in otherwise healthy controls (0-10%) [59–64]. Furthermore, hippocampal malrotation is the most common abnormality of the hippocampus associated with febrile status epilepticus in children . However, the overall significance of the aforementioned studies has been clouded by the use of different criteria to define hippocampal malrotation, and by a lack of correlations with histopathology to directly ascertain the direction and degree of malrotation, as well as any associated changes in the organization of hippocampal fields or subregions. In the present case, hippocampal malrotation (Figure 4) was associated with seizures. Furthermore, the morphology suggested an abnormal persistence of fetal configuration. During normal development, the ventricular surface of the subiculum comes into contact with the ventricular surface of the parahippocampal gyrus between 17–20 weeks of gestation , and these apposed surfaces fuse by the end of gestation  to form, in the mature brain, a solid core of white matter between the subiculum, entorhinal, and transentorhinal areas. Thus, the pathogenic mechanisms underlying hippocampal malrotation in this case may have included decreased hippocampal growth, increased intraventricular pressure, or defective fusion at the ventricular surfaces.
Deleted genes and possible links to brain malformations
Like other subchromosomal deletion syndromes, monosomy 1p36 exhibits considerable phenotypic heterogeneity that may be attributed to multiple variables such as deletion size, genetic background, and intrauterine environment. Notably, the PMG-like cortical dysgenesis in monosomy 1p36 shows incomplete penetrance (~33%)  and variable distribution in the cerebral hemispheres and lobes [10, 12–14, 18, 19]. Likewise, PNH seems to be variable in monosomy 1p36 [9, 15, 18]. Whereas the 1p36 region contains many genes that have been implicated in brain development or function (Table 1), some phenotypes presumably result from a combination of gene deficiencies. For these reasons, at present, it is impossible to definitively identify which gene deletions cause brain and spinal malformations in monosomy 1p36. However, reasonable candidate genes can be proposed on the basis of their previously defined functions in neurodevelopment, especially where critical regions have been defined. The brain phenotypes that seem most likely to have a genetic basis in the present case are micrencephaly, PMG-like cortical dysgenesis, and PNH. (As discussed above, hippocampal malrotation may have been secondary to ventriculomegaly and decreased overall brain growth).
Micrencephaly is a common finding in monosomy 1p36, affecting ~61% of patients , and was severe in the present case. Several important genes that regulate brain size, and neuronal and glial differentiation, were deleted in this patient: these included four HES genes (HES2, HES3, HES4, and HES5), and GNB1. HES (hairy and enhancer of split) genes are basic helix-loop-helix transcriptional repressors that mediate the highly conserved Notch signaling pathway, which, in the nervous system, controls cellular fate choices between neural stem cell (NSC) maintenance and differentiation of neurons and glia [26, 27]. In mice, multiple Hes genes function in a redundant, gene dose-dependent manner to mediate canonical Notch signaling. Mice lacking multiple Hes genes or related effectors undergo accelerated embryonic neuronal differentiation causing a premature and transient excess of neurogenesis, followed by NSC depletion and premature cessation of neurogenesis [27, 67]. GNB1 (guanine nucleotide binding protein [G protein], beta polypeptide 1) encodes a G protein β subunit, one of five Gβ genes in the mouse and human genomes . Gnb1 deficient mice die prematurely in the embryonic or neonatal period with neural tube closure defects and micrencephaly . The concurrent loss of one GNB1 allele and four HES alleles has never been modeled in mice, but would presumably be likely to cause micrencephaly.
The penetrance of PMG-like cortical dysgenesis in monosomy 1p36 has been estimated at ~33%, and the phenotype appears to be linked to a putative critical region between 1.0 Mb and 4.8 Mb from the 1p telomere . This critical region, which was entirely deleted in the present case, includes several genes that might contribute to the PMG-like phenotype. One such candidate is TP73 (tumor protein p73), which encodes a member of the p53 family of transcription factors. In mice, Trp73 (the TP73 ortholog) is required for brain development. Trp73−/− mice show congenital hydrocephalus, hippocampal dysgenesis, absence of the hippocampal sulcus (a folding defect), decreased expression of reelin and calretinin (markers of Cajal-Retzius neurons) in the cortical marginal zone and hippocampal molecular layer, frontal cortex hypoplasia, occipital cortex dyslamination, ventralized cortical patterning with expanded entorhinal-like cortex, increased cortical apoptosis, and probably aberrant connections [44, 45]. Indeed, it was suggested  that “Extrapolation of the [Trp73−/−] mouse brain defect on the human brain would predict a substantial reduction of primary visual cortex and occipitotemporal association areas, a damage that, combined with the entorhinal malformation, would lead to severe cognitive disabilities and mental retardation.” Some defects in Trp73−/− mice, such as the expanded entorhinal-like cortex, seemed to show parallels in the present case of monosomy 1p36 (Figures 3 and 4). However, PMG–like festooning of the supragranular layers was not observed in Trp73−/− mice. Interestingly, human TP73 is expressed monoallelically and is probably imprinted . This fact raises the intriguing possibility that monosomy 1p36 may be associated with either complete loss or complete preservation of TP73 expression, depending on whether the transcriptionally active parental allele was deleted. If TP73 is imprinted and deficiency of TP73 causes a brain malformation (e.g., entorhinal expansion, PMG-like dysgenesis, or PNH), then such phenotypes may be correlated with deletion of a specific parental allele in monosomy 1p36. On the other hand, TP73 allele switching has been documented in some circumstances , and might provide a mechanism to counteract the effects of deleting an active TP73 allele.
Another leading candidate gene in the putative critical region for PMG-like cortical dysgenesis is PEX10 (peroxisomal biogenesis factor 10), which encodes a peroxisomal RING finger ubiquitin ligase required for peroxisome biogenesis . Loss-of-function mutations in PEX10 are one cause of Zellweger syndrome [69, 70], a severe neurological disorder characterized by brain findings of centrosylvian PMG, medial pachygyria, subcortical heterotopias, and simplified inferior olivary nuclei . However, Zellweger syndrome is a recessive disorder, and deletion of one PEX10 allele would not account for brain malformations on its own. Nor was there any history of peroxisomal disorders in the patient’s family.
Reports of PNH in monosomy 1p36 are too few to estimate prevalence or define a critical region, but cases so far suggest limited expressivity with relatively few, small PNH. Usually categorized as a cell migration disorder, PNH may arise from disruptions of cytoskeletal proteins, vesicle trafficking, impaired cell adhesion, ependymal defects, or damage to radial glia [52, 57, 71]. Among genes deleted in the present case, MXRA8 (matrix-remodelling associated 8) encodes an immunoglobulin superfamily cell adhesion molecule that, in adults, is localized to astrocyte endfeet that form the glia limitans and blood–brain barrier [33, 72]. Although the developmental functions of MXRA8 are unknown (since no gene deletion studies have been reported so far), one could speculate that it regulates cell migration or radial glia morphology. Another speculative candidate for contributing to PNH in monosomy 1p36 is CHD5 (chromodomain helicase DNA binding protein 5), which encodes one component of a chromatin remodeling complex that is preferentially expressed in the nervous system . In primary cultured rat neurons, shRNA-mediated knockdown of Chd5 caused downregulation of some neuronal genes (such as Fmr1, Dlx1, and Nefm) and upregulation of others (such as L1cam, Gabrd, and Ampd3) . Some of these changes, such as the upregulation of L1cam (which encodes an immunoglobulin superfamily cell adhesion molecule), might hypothetically interfere with cell migration and cause heterotopia. However, the developmental functions of Chd5 have not been studied in knockout mice and currently remain unknown.
Many other genes deleted in the present case have been implicated in nervous system function and probably contribute to developmental delay, epilepsy, and related neuropsychiatric problems in monosomy 1p36 (Table 1; Additional file 1). However, genes that are expressed only in mature postmitotic neurons are less likely to be involved in the pathogenesis of malformations, and more likely to contribute to abnormalities of neuronal plasticity or function. Overall, in most cases of monosomy 1p36, neurological problems reflect perturbations of both developmental and mature brain functions.
Our findings provide the first neuropathological evidence that multiple malformations of brain and spinal development occur in monosomy 1p36. The unique morphology of PMG-like cortical dysgenesis in the present case suggests that this lesion, in which fusion of the molecular layer was not evident (Figure 3), differs from classic PMG, in which fusion of the molecular layer is a defining feature . More generally, our findings suggest that some types of PMG may exhibit unique morphologic features associated with different genetic and non-genetic etiologies. Finally, our analysis of the deleted chromosome region in this patient allowed us to not only identify candidate genes for malformations, but also propose a novel mechanism of phenotypic diversity in monosomy 1p36, namely the possibility that, due to imprinting, the penetrance of TP73-dependent phenotypes may be linked to deletion of a specific parental allele.
Written informed consent was obtained from the patient’s parents for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in chief of this journal.
Bacterial artificial chromosome
Glial fibrillary acidic protein
Magnetic resonance imaging
Neural stem cell
Patent ductus arteriosus
Periventricular nodular heterotopia
Ventricular septal defect.
We thank Dr. Gina Elsen, Dr. Gordana Juric-Sekhar, Christiane Ulness, and Jill Rosenfeld for technical assistance.
- Heilstedt HA, Ballif BC, Howard LA, Lewis RA, Stal S, Kashork CD, Bacino CA, Shapira SK, Shaffer LG: Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome. Am J Hum Genet 2003, 72: 1200–1212. 10.1086/375179PubMed CentralView ArticlePubMed
- D'Angelo CS, Kohl I, Varela MC, de Castro CI, Kim CA, Bertola DR, Lourenço CM, Koiffmann CP: Extending the phenotype of monosomy 1p36 syndrome and mapping of a critical region for obesity and hyperphagia. Am J Med Genet A 2010, 152A: 102–110. 10.1002/ajmg.a.33160View ArticlePubMed
- Gajecka M, Mackay KL, Shaffer LG: Monosomy 1p36 deletion syndrome. Am J Med Genet C Semin Med Genet 2007, 145C: 346–356. 10.1002/ajmg.c.30154View ArticlePubMed
- Rosenfeld JA, Crolla JA, Tomkins S, Bader P, Morrow B, Gorski J, Troxell R, Forster-Gibson C, Cilliers D, Hislop RG, Lamb A, Torchia B, Ballif BC, Shaffer LG: Refinement of causative genes in monosomy 1p36 through clinical and molecular cytogenetic characterization of small interstitial deletions. Am J Med Genet A 2010, 152A: 1951–1959. 10.1002/ajmg.a.33516View ArticlePubMed
- Shapira SK, McCaskill C, Northrup H, Spikes AS, Elder FF, Sutton VR, Korenberg JR, Greenberg F, Shaffer LG: Chromosome 1p36 deletions: the clinical phenotype and molecular characterization of a common newly delineated syndrome. Am J Hum Genet 1997, 61: 642–650. 10.1086/515520PubMed CentralView ArticlePubMed
- Kurosawa K, Kawame H, Okamoto N, Ochiai Y, Akatsuka A, Kobayashi M, Shimohira M, Mizuno S, Wada K, Fukushima Y, Kawawaki H, Yamamoto T, Masuno M, Imaizumi K, Kuroki Y: Epilepsy and neurological findings in 11 individuals with 1p36 deletion syndrome. Brain Dev 2005, 27: 378–382. 10.1016/j.braindev.2005.02.004View ArticlePubMed
- Buck A, du Souich C, Boerkoel CF: Minimal genotype–phenotype correlation for small deletions within distal 1p36. Am J Med Genet A 2011, 155A: 3164–3169.View ArticlePubMed
- Redon R, Rio M, Gregory SG, Cooper RA, Fiegler H, Sanlaville D, Banerjee R, Scott C, Carr P, Langford C, Cormier-Daire V, Munnich A, Carter NP, Colleaux L: Tiling path resolution mapping of constitutional 1p36 deletions by array-CGH: contiguous gene deletion or “deletion with positional effect” syndrome? J Med Genet 2005, 42: 166–171. 10.1136/jmg.2004.023861PubMed CentralView ArticlePubMed
- Descartes M, Mikhail FM, Franklin JC, McGrath TM, Bebin M: Monosomy1p36.3 and trisomy 19p13.3 in a child with periventricular nodular heterotopia. Pediatr Neurol 2011, 45: 274–278. 10.1016/j.pediatrneurol.2011.06.002View ArticlePubMed
- Dobyns WB, Mirzaa G, Christian SL, Petras K, Roseberry J, Clark GD, Curry CJ, McDonald-McGinn D, Medne L, Zackai E, Parsons J, Zand DJ, Hisama FM, Walsh CA, Leventer RJ, Martin CL, Gajecka M, Shaffer LG: Consistent chromosome abnormalities identify novel polymicrogyria loci in 1p36.3, 2p16.1-p23.1, 4q21.21-q22.1, 6q26-q27, and 21q2. Am J Med Genet A 2008, 146A: 1637–1654. 10.1002/ajmg.a.32293PubMed CentralView ArticlePubMed
- Gajecka M, Saitta SC, Gentles AJ, Campbell L, Ciprero K, Geiger E, Catherwood A, Rosenfeld JA, Shaikh T, Shaffer LG: Recurrent interstitial 1p36 deletions: Evidence for germline mosaicism and complex rearrangement breakpoints. Am J Med Genet A 2010, 152A: 3074–3083. 10.1002/ajmg.a.33733PubMed CentralView ArticlePubMed
- Battaglia A, Hoyme HE, Dallapiccola B, Zackai E, Hudgins L, McDonald-McGinn D, Bahi-Buisson N, Romano C, Williams CA, Brailey LL, Zuberi SM, Carey JC: Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation. Pediatrics 2008, 121: 404–410. 10.1542/peds.2007-0929View ArticlePubMed
- Campeau PM, Ah Mew N, Cartier L, Mackay KL, Shaffer LG, Der Kaloustian VM, Thomas MA: Prenatal diagnosis of monosomy 1p36: a focus on brain abnormalities and a review of the literature. Am J Med Genet A 2008, 146A: 3062–3069. 10.1002/ajmg.a.32563View ArticlePubMed
- Faivre L, Morichon-Delvallez N, Viot G, Martinovic J, Pinson MP, Aubry JP, Raclin V, Edery P, Dumez Y, Munnich A, Vekemans M: Prenatal detection of a 1p36 deletion in a fetus with multiple malformations and a review of the literature. Prenat Diagn 1999, 19: 49–53. 10.1002/(SICI)1097-0223(199901)19:1<49::AID-PD450>3.0.CO;2-CView ArticlePubMed
- Neal J, Apse K, Sahin M, Walsh CA, Sheen VL: Deletion of chromosome 1p36 is associated with periventricular nodular heterotopia. Am J Med Genet A 2006, 140: 1692–1695.View ArticlePubMed
- Puvabanditsin S, Garrow E, Patel N, D'Elia A, Zaafran A, Phattraprayoon N, Davis SE: Choroid plexus hyperplasia and monosomy 1p36: report of new findings. J Child Neurol 2008, 23: 922–925. 10.1177/0883073808314364View ArticlePubMed
- Ribeiro Mdo C, Gama De Sousa S, Freitas MM, Carrilho I, Fernandes I: Bilateral perisylvian polymicrogyria and chromosome 1 anomaly. Pediatr Neurol 2007, 36: 418–420. 10.1016/j.pediatrneurol.2007.01.015View ArticlePubMed
- Saito S, Kawamura R, Kosho T, Shimizu T, Aoyama K, Koike K, Wada T, Matsumoto N, Kato M, Wakui K, Fukushima Y: Bilateral perisylvian polymicrogyria, periventricular nodular heterotopia, and left ventricular noncompaction in a girl with 10.5–11.1 Mb terminal deletion of 1p36. Am J Med Genet A 2008, 146A: 2891–2897. 10.1002/ajmg.a.32556View ArticlePubMed
- Saito Y, Kubota M, Kurosawa K, Ichihashi I, Kaneko Y, Hattori A, Komaki H, Nakagawa E, Sugai K, Sasaki M: Polymicrogyria and infantile spasms in a patient with 1p36 deletion syndrome. Brain Dev 2011, 33: 437–441. 10.1016/j.braindev.2010.07.004View ArticlePubMed
- Englund C, Folkerth RD, Born D, Lacy JM, Hevner RF: Aberrant neuronal-glial differentiation in Taylor-type focal cortical dysplasia (type IIA/B). Acta Neuropathol 2005, 109: 519–533. 10.1007/s00401-005-1005-9View ArticlePubMed
- Hevner RF, Daza RA, Englund C, Kohtz J, Fink A: Postnatal shifts of interneuron position in the neocortex of normal and reeler mice: evidence for inward radial migration. Neuroscience 2004, 124: 605–618. 10.1016/j.neuroscience.2003.11.033View ArticlePubMed
- Bejjani BA, Saleki R, Ballif BC, Rorem EA, Sundin K, Theisen A, Kashork CD, Shaffer LG: Use of targeted array-based CGH for the clinical diagnosis of chromosomal imbalance: is less more? Am J Med Genet A 2005, 134: 259–267.View ArticlePubMed
- Barkovich AJ, Koch TK, Carrol CL: The spectrum of lissencephaly: report of ten patients analyzed by magnetic resonance imaging. Ann Neurol 1991, 30: 139–146. 10.1002/ana.410300204View ArticlePubMed
- Hevner RF: Layer-specific markers as probes for neuron type identity in human neocortex and malformations of cortical development. J Neuropathol Exp Neurol 2007, 66: 101–109. 10.1097/nen.0b013e3180301c06View ArticlePubMed
- Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D: The human genome browser at UCSC. Genome Res 2002, 12: 996–1006.PubMed CentralView ArticlePubMed
- Kageyama R, Ohtsuka T, Kobayashi T: The Hes gene family: repressors and oscillators that orchestrate embryogenesis. Development 2007, 134: 1243–1251. 10.1242/dev.000786View ArticlePubMed
- Kageyama R, Ohtsuka T, Kobayashi T: Roles of Hes genes in neural development. Dev Growth Differ 2008,50(Suppl 1):S97-S103.View ArticlePubMed
- Chen Y, Derin R, Petralia RS, Li M: Actinfilin, a brain-specific actin-binding protein in postsynaptic density. J Biol Chem 2002, 277: 30495–30501. 10.1074/jbc.M202076200View ArticlePubMed
- Huzé C, Bauché S, Richard P, Chevessier F, Goillot E, Gaudon K, Ben Ammar A, Chaboud A, Grosjean I, Lecuyer HA, Bernard V, Rouche A, Alexandri N, Kuntzer T, Fardeau M, Fournier E, Brancaccio A, Rüegg MA, Koenig J, Eymard B, Schaeffer L, Hantaï D: Identification of an agrin mutation that causes congenital myasthenia and affects synapse function. Am J Hum Genet 2009, 85: 155–167. 10.1016/j.ajhg.2009.06.015PubMed CentralView ArticlePubMed
- Giraldez T, Afonso-Oramas D, Cruz-Muros I, Garcia-Marin V, Pagel P, González-Hernández T, Alvarez De La Rosa D: Cloning and functional expression of a new epithelial sodium channel delta subunit isoform differentially expressed in neurons of the human and monkey telencephalon. J Neurochem 2007, 102: 1304–1315. 10.1111/j.1471-4159.2007.04622.xView ArticlePubMed
- Ahmad-Annuar A, Ciani L, Simeonidis I, Herreros J, Fredj NB, Rosso SB, Hall A, Brickley S, Salinas PC: Signaling across the synapse: a role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release. J Cell Biol 2006, 174: 127–139. 10.1083/jcb.200511054PubMed CentralView ArticlePubMed
- Long JM, LaPorte P, Paylor R, Wynshaw-Boris A: Expanded characterization of the social interaction abnormalities in mice lacking Dvl1 . Genes Brain Behav 2004, 3: 51–62. 10.1046/j.1601-183x.2003.00045.xView ArticlePubMed
- Yonezawa T, Ohtsuka A, Yoshitaka T, Hirano S, Nomoto H, Yamamoto K, Ninomiya Y: Limitrin, a novel immunoglobulin superfamily protein localized to glia limitans formed by astrocyte endfeet. Glia 2003, 44: 190–204. 10.1002/glia.10279View ArticlePubMed
- Allen JM, Zamurs L, Brachvogel B, Schlötzer-Schrehardt U, Hansen U, Lamandé SR, Rowley L, Fitzgerald J, Bateman JF: Mice lacking the extracellular matrix protein WARP develop normally but have compromised peripheral nerve structure and function. J Biol Chem 2009, 284: 12020–12030. 10.1074/jbc.M806968200PubMed CentralView ArticlePubMed
- Wu JI, Rajendra R, Barsi JC, Durfee L, Benito E, Gao G, Kuruvilla M, Hrdlicková R, Liss AS, Artzt K: Targeted disruption of Mib2 causes exencephaly with a variable penetrance. Genesis 2007, 45: 722–727. 10.1002/dvg.20349View ArticlePubMed
- Gajecka M, Yu W, Ballif BC, Glotzbach CD, Bailey KA, Shaw CA, Kashork CD, Heilstedt HA, Ansel DA, Theisen A, Rice R, Rice DP, Shaffer LG: Delineation of mechanisms and regions of dosage imbalance in complex rearrangements of 1p36 leads to a putative gene for regulation of cranial suture closure. Eur J Hum Genet 2005, 13: 139–149. 10.1038/sj.ejhg.5201302View ArticlePubMed
- Okae H, Iwakura Y: Neural tube defects and impaired neural progenitor cell proliferation in gbeta1-deficient mice. Dev Dyn 2010, 239: 1089–1101. 10.1002/dvdy.22256View ArticlePubMed
- Dibbens LM, Feng HJ, Richards MC, Harkin LA, Hodgson BL, Scott D, Jenkins M, Petrou S, Sutherland GR, Scheffer IE, Berkovic SF, Macdonald RL, Mulley JC: GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies. Hum Mol Genet 2004, 13: 1315–1319. 10.1093/hmg/ddh146View ArticlePubMed
- Atanasoski S, Notterpek L, Lee HY, Castagner F, Young P, Ehrengruber MU, Meijer D, Sommer L, Stavnezer E, Colmenares C, Suter U: The protooncogene Ski controls Schwann cell proliferation and myelination. Neuron 2004, 43: 499–511. 10.1016/j.neuron.2004.08.001View ArticlePubMed
- Colmenares C, Heilstedt HA, Shaffer LG, Schwartz S, Berk M, Murray JC, Stavnezer E: Loss of the SKI proto-oncogene in individuals affected with 1p36 deletion syndrome is predicted by strain-dependent defects in Ski −/− mice. Nat Genet 2002, 30: 106–109. 10.1038/ng770View ArticlePubMed
- Powers JM, Moser HW: Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol 1998, 8: 101–120.View ArticlePubMed
- Lo Vasco VR: Role of phosphoinositide-specific phospholipase C η2 in isolated and syndromic mental retardation. Eur Neurol 2011, 65: 264–269. 10.1159/000327307View ArticlePubMed
- Kremer T, Kempf C, Wittenmayer N, Nawrotzki R, Kuner T, Kirsch J, Dresbach T: Mover is a novel vertebrate-specific presynaptic protein with differential distribution at subsets of CNS synapses. FEBS Lett 2007, 581: 4727–4733. 10.1016/j.febslet.2007.08.070View ArticlePubMed
- Meyer G, Cabrera Socorro A, Perez Garcia CG, Martinez Millan L, Walker N, Caput D: Developmental roles of p73 in Cajal-Retzius cells and cortical patterning. J Neurosci 2004, 24: 9878–9887. 10.1523/JNEUROSCI.3060-04.2004View ArticlePubMed
- Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, Vagner C, Bonnet H, Dikkes P, Sharpe A, McKeon F, Caput D: p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 2000, 404: 99–103. 10.1038/35003607View ArticlePubMed
- Perkowski JJ, Murphy GG: Deletion of the mouse homolog of KCNAB2, a gene linked to monosomy 1p36, results in associative memory impairments and amygdala hyperexcitability. J Neurosci 2011, 31: 46–54. 10.1523/JNEUROSCI.2634-10.2011PubMed CentralView ArticlePubMed
- Potts RC, Zhang P, Wurster AL, Precht P, Mughal MR, Wood WH 3rd, Zhang Y, Becker KG, Mattson MP, Pazin MJ: CHD5 , a brain-specific paralog of Mi2 chromatin remodeling enzymes, regulates expression of neuronal genes. PLoS One 2011, 6: e24515. 10.1371/journal.pone.0024515PubMed CentralView ArticlePubMed
- Yang JW, Czech T, Yamada J, Csaszar E, Baumgartner C, Slavc I, Lubec G: Aberrant cytosolic acyl-CoA thioester hydrolase in hippocampus of patients with mesial temporal lobe epilepsy. Amino Acids 2004, 27: 269–275. 10.1007/s00726-004-0138-9View ArticlePubMed
- Donaudy F, Zheng L, Ficarella R, Ballana E, Carella M, Melchionda S, Estivill X, Bartles JR, Gasparini P: Espin gene ( ESPN ) mutations associated with autosomal dominant hearing loss cause defects in microvillar elongation or organisation. J Med Genet 2006, 43: 157–161.PubMed CentralView ArticlePubMed
- Maystadt I, Rezsöhazy R, Barkats M, Duque S, Vannuffel P, Remacle S, Lambert B, Najimi M, Sokal E, Munnich A, Viollet L, Verellen-Dumoulin C: The nuclear factor kappaB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset. Am J Hum Genet 2007, 81: 67–76. 10.1086/518900PubMed CentralView ArticlePubMed
- Guerrini R, Dobyns WB, Barkovich AJ: Abnormal development of the human cerebral cortex: genetics, functional consequences and treatment options. Trends Neurosci 2008, 31: 154–162. 10.1016/j.tins.2007.12.004View ArticlePubMed
- Aronica E, Becker AJ, Spreafico R: Malformations of cortical development. Brain Pathol 2012, 22: 380–401. 10.1111/j.1750-3639.2012.00581.xView ArticlePubMed
- Ferrer I: A Golgi analysis of unlayered polymicrogyria. Acta Neuropathol 1984, 65: 69–76. 10.1007/BF00689830View ArticlePubMed
- Judkins AR, Martinez D, Ferreira P, Dobyns WB, Golden JA: Polymicrogyria includes fusion of the molecular layer and decreased neuronal populations but normal cortical laminar organization. J Neuropathol Exp Neurol 2011, 70: 438–443. 10.1097/NEN.0b013e31821ccf1cPubMed CentralView ArticlePubMed
- Bahi-Buisson N, Poirier K, Boddaert N, Fallet-Bianco C, Specchio N, Bertini E, Caglayan O, Lascelles K, Elie C, Rambaud J, Baulac M, An I, Dias P, Des Portes V, Moutard ML, Soufflet C, El Maleh M, Beldjord C, Villard L, Chelly J: GPR56 -related bilateral frontoparietal polymicrogyria: further evidence for an overlap with the cobblestone complex. Brain 2010, 133: 3194–3209. 10.1093/brain/awq259View ArticlePubMed
- Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB: A developmental and genetic classification for malformations of cortical development. Neurology 2005, 65: 1873–1887. 10.1212/01.wnl.0000183747.05269.2dView ArticlePubMed
- Ferland RJ, Batiz LF, Neal J, Lian G, Bundock E, Lu J, Hsiao YC, Diamond R, Mei D, Banham AH, Brown PJ, Vanderburg CR, Joseph J, Hecht JL, Folkerth R, Guerrini R, Walsh CA, Rodriguez EM, Sheen VL: Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia. Hum Mol Genet 2009, 18: 497–516.PubMed CentralView ArticlePubMed
- Garbelli R, Rossini L, Moroni RF, Watakabe A, Yamamori T, Tassi L, Bramerio M, Russo GL, Frassoni C, Spreafico R: Layer-specific genes reveal a rudimentary laminar pattern in human nodular heterotopia. Neurology 2009, 73: 746–753. 10.1212/WNL.0b013e3181af3397View ArticlePubMed
- Bernasconi N, Kinay D, Andermann F, Antel S, Bernasconi A: Analysis of shape and positioning of the hippocampal formation: an MRI study in patients with partial epilepsy and healthy controls. Brain 2005, 128: 2442–2452. 10.1093/brain/awh599View ArticlePubMed
- Donmez FY, Yildirim M, Erkek N, Demir Karacan C, Coskun M: Hippocampal abnormalities associated with various congenital malformations. Childs Nerv Syst 2009, 25: 933–939. 10.1007/s00381-009-0823-9View ArticlePubMed
- Gamss RP, Slasky SE, Bello JA, Miller TS, Shinnar S: Prevalence of hippocampal malrotation in a population without seizures. AJNR Am J Neuroradiol 2009, 30: 1571–1573. 10.3174/ajnr.A1657PubMed CentralView ArticlePubMed
- Kuchukhidze G, Koppelstaetter F, Unterberger I, Dobesberger J, Walser G, Zamarian L, Haberlandt E, Maier H, Ortler M, Gotwald T, Gelpi E, Czech T, Feucht M, Bauer G, Delazer M, Felber S, Trinka E: Hippocampal abnormalities in malformations of cortical development: MRI study. Neurology 2010, 74: 1575–1582. 10.1212/WNL.0b013e3181df09b6View ArticlePubMed
- Montenegro MA, Kinay D, Cendes F, Bernasconi A, Bernasconi N, Coan AC, Li LM, Guerreiro MM, Guerreiro CA, Lopes-Cendes I, Andermann E, Dubeau F, Andermann F: Patterns of hippocampal abnormalities in malformations of cortical development. J Neurol Neurosurg Psychiatry 2006, 77: 367–371.PubMed CentralView ArticlePubMed
- Shinnar S, Bello JA, Chan S, Hesdorffer DC, Lewis DV, Macfall J, Pellock JM, Nordli DR, Frank LM, Moshe SL, Gomes W, Shinnar RC, Sun S, FEBSTAT Study Team: MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study. Neurology 2012, 79: 871–877. 10.1212/WNL.0b013e318266fcc5PubMed CentralView ArticlePubMed
- Bayer SA, Altman J: The Human Brain During the Second Trimester. Boca Raton, FL: CRC Press; 2005.View Article
- Bayer SA, Altman J: The Human Brain During the Third Trimester. Boca Raton, FL: CRC Press; 2004.
- Imayoshi I, Sakamoto M, Yamaguchi M, Mori K, Kageyama R: Essential roles of Notch signaling in maintenance of neural stem cells in developing and adult brains. J Neurosci 2010, 30: 3489–3498. 10.1523/JNEUROSCI.4987-09.2010View ArticlePubMed
- Mai M, Qian C, Yokomizo A, Tindall DJ, Bostwick D, Polychronakos C, Smith DI, Liu W: Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene 1998, 17: 1739–1741. 10.1038/sj.onc.1202099View ArticlePubMed
- Waterham HR, Ebberink MS: Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim Biophys Acta 1822, 2012: 1430–1441.
- Warren DS, Wolfe BD, Gould SJ: Phenotype-genotype relationships in PEX10-deficient peroxisome biogenesis disorder patients. Hum Mutat 2000, 15: 509–521. 10.1002/1098-1004(200006)15:6<509::AID-HUMU3>3.0.CO;2-#View ArticlePubMed
- Santi MR, Golden JA: Periventricular heterotopia may result from radial glial fiber disruption. J Neuropathol Exp Neurol 2001, 60: 856–862.PubMed
- Jung YK, Jin JS, Jeong JH, Kim HN, Park NR, Choi JY: DICAM, a novel dual immunoglobulin domain containing cell adhesion molecule interacts with alphavbeta3 integrin. J Cell Physiol 2008, 216: 603–614. 10.1002/jcp.21438View ArticlePubMed
- Thompson PM, Gotoh T, Kok M, White PS, Brodeur GM: CHD5 , a new member of the chromodomain gene family, is preferentially expressed in the nervous system. Oncogene 2003, 22: 1002–1011. 10.1038/sj.onc.1206211View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.